What are the risks of serotonin syndrome when using MDMA and SSRIs together?
Zenodo (CERN European Organization for Nuclear Research) July 7, 2026 DOI: 10.5281/zenodo.21242234 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractCombined use of MDMA and SSRIs may increase the risk of serotonin syndrome, though evidence is limited or indirect. Healthcare providers are advised to remain alert for symptoms of this condition and to discourage such drug interactions.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | MDMA Serotonin |
| Keywords | Serotonin syndrome Drug Mirtazapine Health care |
| Key finding | Combined use of MDMA and SSRIs may increase the risk of serotonin syndrome. |
Abstract
There is limited or indirect evidence suggesting that combined use of MDMA and SSRIs may increase the risk of serotonin syndrome. Healthcare providers should be vigilant in identifying symptoms and discourage such drug interactions.